Finch Therapeutics Raises $36 Million Series B, Bringing Total to $77 Million Post author:Sam Post published:February 28, 2018 Post category:BioPharma Finch Therapeutics closed on an oversubscribed Series B financing worth $36 million. Source: BioSpace You Might Also Like Oventus Extension Of Share Purchase Plan July 13, 2017 Heads Up Tesaro: AstraZeneca PLC, Merck & Co.'s Ovarian Cancer Drug Just Got Expanded Use From the FDA August 17, 2017 VANC Pharmaceuticals Receives Updated Health Canada Approval For Hema-Fer With New Indication For Use In Pregnancy August 24, 2017
Heads Up Tesaro: AstraZeneca PLC, Merck & Co.'s Ovarian Cancer Drug Just Got Expanded Use From the FDA August 17, 2017
VANC Pharmaceuticals Receives Updated Health Canada Approval For Hema-Fer With New Indication For Use In Pregnancy August 24, 2017
